Skip to main content
. 2023 Jan 12;13:1096071. doi: 10.3389/fgene.2022.1096071

FIGURE 4.

FIGURE 4

METTL3, METTL14, WTAP and CBLL1 expression in non-malignant and prostate cancer cell lines; mRNA expression analysed by qRT-PCR relative to β-actin (A–D) and protein expression analysed using western blot (E). METTL3 protein expression as previously reported in Haigh et al. (2022). *p ≤ .05, **p ≤ .005, ***p ≤ .001, ****p ≤ .0001 by unpaired t-test.